Axium PrimeTM FC-25-50-3DRecalls & reported problems
Micro Therapeutics, Inc. · COIL FC-25-50-3D V03 · Class 2 · Implant
All models of Axium PrimeTM (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00847536034488), received between Jul 31, 2022 and Jul 31, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Material Deformation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Material Deformation1
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 31, 2022Material Deformation; Physical Resistance/Sticking; Material Deformation; Physical Resistance/Sticking
MEDTRONIC RECEIVED INFORMATION REPORTING THAT THE FRAMING COIL WAS THE FIRST TO BE USED IN THE PROCEDURE. THE COIL HAD RESISTANCE AND BECAME STUCK IN THE ECHELON MICROCATHETER. THE SURGEON REMOVED THE SYSTEM. THERE WAS NO DAMAGE NOTED TO THE CATHETER BUT THE COIL WAS OBSERVED TO BE DAMAGED. THE PATIENT VESSEL WAS RE-ACCESSED AND THE REPLACEMENT COILS WERE DELIVERED AND DETACHED WITHOUT ISSUE. IT WAS NOTED THE FRAMING COIL AND ALL ACCESSORY DEVICES WERE PREPARED ACCORDING TO THE INSTRUCTIONS FOR USE (IFU) AND THE CATHETER WAS FLUSHED CONTINUOUSLY PER IFU. THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS ASSOCIATED WITH THIS EVENT. THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE TO TREAT UNSPECIFIED NEUROVASCULAR ABNORMALITIES. ADDITIONAL INFORMATION WAS RECEIVED. THE RESISTANCE OCCURRED IN THE DISTAL SECTION OF THE CATHETER. THE COIL DID COME OUT OF THE INTRODUCER SHEATH SMOOTHLY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15136938 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page